Respiratory

Filter

Patient with persistent cough during diabetes medication review, concept image for GLP-1 receptor agonists and chronic cough

Do GLP-1 Receptor Agonists Raise Chronic Cough Risk?

February 2026

GLP-1 receptor agonists were associated with increased incident chronic cough among adults with type 2 diabetes, in US EHR records.

patient exercise monitoring

CHEST 2025: Improved Cardiac Function with Treprostinil in ASCENT Trial

Inhaled treprostinil treatment improved cardiac effort and physiological function in patients with pulmonary hypertension–interstitial lung disease.

Illustration showing the human heart and pulmonary arteries, highlighting right ventricular function and pulmonary arterial hypertension.

CHEST 2025: GLP-1 Receptor Agonists Cut Right Heart Failure Risk

GLP-1 receptor agonists significantly reduced the risk of right heart failure in patients with pulmonary arterial hypertension compared with SGLT2-inhibitors.

Scientist performing laboratory microbiology testing with test tubes and pipette to analyze respiratory samples in a biosafety cabinet.

Nasal Irrigation Rivals Sputum Testing in Cystic Fibrosis

Nasal irrigation could provide a practical, non-invasive alternative for monitoring airway microbiology in people with cystic fibrosis.

Nebulized therapy concept for COPD symptom relief with ensifentrine

CHEST 2025: Ensifentrine Boosts Quality of Life in COPD

Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.

Laboratory technician conducting AATD diagnostic test using genotyping and sequencing technology.

CHEST 2025: New Algorithm Enhances AATD Diagnosis Accuracy

Alpha-1 antitrypsin deficiency (AATD) remains a frequently underdiagnosed condition that predisposes individuals to chronic lung and liver diseases.

CT scan concept of lung cancer with EGFR mutation and chemotherapy treatment

Osimertinib Plus Chemo Extends Survival in EGFR-Mutated NSCLC

Osimertinib plus chemotherapy improved overall survival versus monotherapy in EGFR-mutated advanced NSCLC in a Phase III trial.

Elderly woman using a nebulizer for respiratory treatment while holding hands with a healthcare provider

CHEST 2025: Nerandomilast Shows Promise in Slowing IPF Decline

In a Phase III trial, the addition of nerandomilast demonstrated a promising ability to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF).

Nirsevimab Lowers RSV Hospitalization in US Infants

Nirsevimab administration was linked to lower RSV hospitalization among U.S. infants this season in analysis of real-world data.

Loading posts...

« Previous 1 … 5 6 7 8 9 … 29 Next »